Hengrui Pharma (600276.SH; 01276.HK) today announced it has entered into agreements with GSK plc (LSE/NYSE: GSK) to develop up to 12 innovative medicines, adding significant value to the globalization ...

The current deglobalization policy of the Trump administration in the form of tariffs, as well as its disregard for ...

Kendrick Perkins and Richard Jefferson voice concerns about NBA globalization, citing its impact on American player ...

Hengrui Pharma enters agreement and with GSK to develop up to 12 innovative medicines across respiratory, immunology & inflammation & oncology: Jiangsu, China Tuesday, July 29, 20 ...

Hengrui Pharma partners with GSK to develop 12 innovative medicines, enhancing COPD treatment and expanding global growth ...

GSK plc has entered into agreements with China-based biotechnology company Hengrui Pharma to develop up to 12 innovative ...

The United States and China are poised to start a fresh round of talks in Sweden, aiming to extend a temporary trade truce ...

First Trust Advisors L.P. ("First Trust"), a leading exchange-traded fund ("ETF") provider and asset manager, announced today that it has launched a new ETF, the First Trust RBA Deglobalization ETF ...

And if you can’t buy, you rent — which is increasingly a financial cul-de-sac. Over 22 million U.S. households now pay more ...

The Global Champagne Market, valued at USD 7.72 billion in 2024, is poised to reach USD 12.74 billion by 2033, experiencing a CAGR of 5.72%. Key driv ...

The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.

On Sunday, European Commission President Ursula von der Leyen struck a deal with U.S. President Donald Trump to avoid an ...